Afleveringen
-
On this special episode of the Pharma Podcast, we're honouring Rare Disease Month this February by delving into the personal and profound stories from the front lines of rare diseases in Canada. Our focus is on the unique challenges, healthcare experiences, and the resilience required to navigate life with a rare condition. In celebration of this important month, Iām thrilled to have Dr. Sonia Rehal with us. Sonia is not only courageously living with a rare disease but also actively participating in raising awareness and advocating for better support and research for rare diseases in Canada.
Sonia's journey offers us a window into the day-to-day realities faced by individuals with rare diseases, from the quest for diagnosis to access to specialised care, and underscores the importance of community support. Her insights are invaluable in dispelling misconceptions about rare diseases and highlighting the ongoing efforts to improve the lives of those affected.
Join us as we explore Sonia's story, the broader landscape of rare diseases in Canada, and what hope and advancements lie on the horizon for patients and their families.
Through this episode, we hope to convey a powerful message: while each rare disease may affect a small number of individuals, collectively, these conditions are not that rare at all.
Lipodystrophy Canada Website:
https://lipodystrophy-canada-foundation.wiredwebsites.org/
Facebook Page:
https://www.facebook.com/profile.php?id=100092509705779
Our Email address:
-
On this episode of the PharmaPodcast, we will discuss Florida, and its plans to import Drugs from Canada. Florida is making headlines for its bold move to import prescription drugs from Canada, a strategy aimed at reducing healthcare costs in that state. This shift could potentially transform the landscape of pharmaceutical importation in the US and set a precedent for other states.
To help us better understand this complex and fascinating topic, Iām thrilled to have DANI Peters with us. Dani is President of Magnet Strategy Group Inc. and Special Advisor at the Alliance for Safe Online Pharmacy Canada. Dani is an expert in healthcare policy and has been closely following the developments in drug importation policies.
Contact Details for Dani Peters:
www.buysaferx.pharmacy/canada
[email protected] -
Zijn er afleveringen die ontbreken?
-
On this episode of the Pharma Podcast, my guest is Lois Brown, President of Health Partners International Canada, and on this episode of the Pharma Podcast, we discuss the transformative impact of global health initiatives, the critical role of pharmaceutical partnerships in advancing healthcare worldwide, and the inspiring achievements and future goals of HPIC in its mission to improve health and save lives.
HPIC is now working in 39 countries including our latest emergency response to support victims in Israel and Gaza.
https://hpicanada.ca/donate/ -
On this episode of the PharmaPodcast, my guest is Tara Cowling, President and Managing Principal at Medlior Health Outcomes Research. Tara is a leader in Real World Evidence, HTA (Health Technology Assessments) and Outcomes Research.
We delve into the pivotal role of Real World Evidence (RWE) in drug reimbursement and market access. Join us as we explore the significance of peripheral services like Patient Support Programs and speciality pharmacies in generating crucial Real World Data and shaping healthcare decisions.
Tara shares invaluable insights on how we can bridge the gap between real-world experiences and compelling Real World Evidence. Together, we'll tackle historical concerns, biases, and data quality issues, discovering innovative ways to overcome these challenges.
Contact Details:
Tara Cowling, MA (Oxon), MSc (she/her)President and Managing Principal
https://www.medlior.com/Suite 300 ā 160 Quarry Park Blvd SE
Calgary, Alberta T2C 3G3
1-403-460-2616
-
On this episode of the PharmaPodcast, my guest is Greg Rutherford, Chief Commercial Officer at Apex Labs, a Vancouver based patient driven pharmaceutical company that develops and commercialises clinically evaluated psilocybin-derived treatments to tackle the most critical unmet need in depression, anxiety, and PTSD among Veterans and the general public.
Greg and I will delve into the fascinating world of Psilocybin and its remarkable potential to aid patients with PTSD while promoting overall brain health. Join us as we explore the science behind Psilocybin, its effects on the brain, and the emerging research supporting its therapeutic benefits. Our expert guest will discuss the rationale for using Psilocybin in PTSD treatment, highlight key findings from clinical studies, and shed light on how Psilocybin therapy differs from traditional approaches. We'll also address the potential risks, legal considerations, and the importance of public and professional education. Tune in to learn about the promising possibilities of Psilocybin as we uncover its role in unlocking the mind for healing and well-being. -
On this episode of the PharmaPodcast, I have an extra special guest. Artem Brytchenko is CEO at Platforce, a company based in Ukraine that he continues to run, in spite of all the adversity he is facing during a time of war. Iām sure you will find this interview not just informative, but also Inspirational.
Contact Information:
Artem BrytchenkoChief Executive Officer | Platforce
W: https://platforce.io/
-
On this episode of the Pharma Podcast, my extra-special guest is Dr. Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare Disorders.
To mark Rare Disease Day, which we celebrate on the last day of February, I can think of no better guest than Dr. Durhane Wong-Rieger to bring awareness to Rare Disease Day.
She also gives a great overview of CORD and its mission.
To learn more about CORD, upcoming events, or to make a donation, please visit: www.raredisorders.ca
You can also follow CORD on social media:
https://www.facebook.com/RareDisorders
https://twitter.com/raredisorders
https://www.youtube.com/user/CORDRareDisorders
-
On this episode of the Pharma Podcast, my guest is Dr, Drew Taylor, founder and CEO of ACORN BIOLABS.
As an entrepreneur and regenerative medicine pioneer, Drew is making breakthrough medicine accessible for everyday people. After simultaneously earning a PhD in Biomedical Engineering at the University of Toronto and playing professional baseball, Drew worked as part of Mount Sinai Hospitalās Bio-engineering of Skeletal Tissues Team, then as Chief Science Officer at Epic Capital Management.
In 2017, Drew co-founded Acorn Biolabs, to help more people access the future of regenerative medicine by providing affordable, accessible, and non-invasive cell banking.
Drew and I discuss his journey to entrepreneurship, and the NEAR FUTURE of Regenerative medicine.
Contact Information:
Drew Taylor, MSc, PhDChief Executive Officer | Acorn Biolabs Inc.
W: acorn.me
Instagram: @drdrewtaylorSave your cells from aging.
Join our waitlist | Sign-up for the newsletter -
Welcome to the Pharma Podcast, conversations with industry experts and business leaders about important and current topics in Canadian pharma, biotech and medtech.
On this episode of the PharmaPodcast, my guest is Jesse Buckstein, Principle at CPoint CapitalJesse and I discuss the Healthcare investment market in Canada - How a changing economy is affecting investor appetites.
Contact Information for Jesse:
CPOINT Capital
512-555 Richmond Street West, Toronto, ON, M5V 3B1
T: +1 905 881 4440 x 203 | M: +1 647 981 4293 | F: +1 647 847 9055
E: [email protected] | W: www.cpointcapital.com -
Welcome to the Pharma Podcast, conversations with industry experts and business leaders about important and current topics in Canadian pharma, biotech and medtech.
On this episode of the PharmaPodcast, my guest is Brian Bloom, CEO, Bloom Burton
On the heels of the Bloom Burton Healthcare Investor Conference, which was held in Toronto on May 2-3, Brian and I will discuss the latest developments in Canadian healthcare companies.
Contact Information for Bloom Burton:
[email protected]
https://www.bloomburton.com/contact-us/ -
Support Health Partners Ukraine Relief efforts
On this episode of the PharmaPodcast my guest is Lois Brown, President of Health Partners International of Canada. Lois and I discuss Health Partners and its response to the Emergency in Ukraine.
Health Partners is actively responding to the crisis in Ukraine by providing Humanitarian Medical Kits to Ukrainians in-country and in neighbouring refugee camps.Over the next few months, Health Partners aims to send 400 Humanitarian Medical Kits to provide urgently-needed medical relief, and need to raise $240,000 in order to mobilize these medicines.
Please support our efforts by making a donation to our āUkraine Emergency Fundā today.
https://hpicanada.ca/donate/ -
On this episode of The Pharma Podcast, my guest is Raj Indupuri, CEO, eClinical Solutions.
Raj and I explore the Build vs. Buy Pendulum: Should CROs buy technology capabilities or should they develop them in-house?ā
Contact Information:
Raj Indupuri
CEO
eClinical Solutions
[email protected]
tel. 508.594.6313 -
On this episode of the PharmaPodcast my guest is Michael Cloutier, founding partner at Accelera Canada. Mike has been CEO/President/GM of seven Canadian companies and affiliates including: Searle, Pharmacia, AstraZeneca, COTI, InterMune, PTC Therapeutics, Diabetes Canada!
Mike and I discuss the current commercial landscape for pharma in Canada, including its challenges and opportunities.
Contact Information:
Michael Cloutier
Founding Partner
[email protected]
289-208-4191210B-219 Dufferin Street,
Toronto, ON M6K 3J1 -
On this episode of the Pharma Podcast my guest is Nicole Serena, President and Managing Director at PSPConsult, a division of Waldron & Associates and co-founder of PSPCertify ā a new Certification Program for PSP Professionals.
Nicole and I discuss BioSimilars and the need for Patient Support Programs to support them.
Contact Information:
Nicole Serena
President & Managing Director PSPConsult
A division of Waldron & Associates
[email protected]
www.pspconsult.ca -
Ryan Clarke is CEO and founder of Advocacy Solutions and a Senior Partner at Accelera Canada, where he is responsible for Advocacy & Stakeholder Relations.
In this episode of The Pharma Podcast Ryan discusses CADTH (Canadian Agency for Drugs and Technologies in Health) and the streamlined input processes for both patients and Clinicians.
Contact Information:
[email protected]C: 416.919.9532
Toll Free: 1.800.250.1569
219 Dufferin Street, Unit 210B, Toronto ON, M6K 3J1 -
On this episode of The Pharma Podcast my guest is Lindy Forte, Senior Partner, Health Technology Assessment at Accelera Canada .
Lindy discusses the Patented Medicines Pricing Review Board (PMPRB), the amendments to the Patented Medicines Regulations and its impact on Drug prices in Canada.
She also shares her thoughts on what she likes about the new regulations, and some potential shortcomings.
This episode of the podcast is a must listen to for any pharma professional considering launching a new drug in Canada.
Contact Information:
www.acceleracanada.com
[email protected] -
In this episode of the PharmaPodcast my guest is Vijay Wadhawan, Vice President, Health and Wellness at Environics Research.
Getting fast, convenient access to healthcare can be frustrating for many Canadians. COVID19 has exacerbated existing challenges. Telemedicine is a new delivery channel for medicine with the potential to make healthcare more accessible.
Vijay discusses the findings from a recent survey conducted by Environics Research to understand Canadian attitudes toward healthcare and telemedicine.
Contact Information for Vijay Wadhawan:
linkedin.com/in/vwadhawan
[email protected]
https://environicsresearch.com/capabilities-insights/health-wellness/ -
In this episode of The Pharma Podcast, my guest is Brian Bloom, co-founder and CEO of Bloom Burton.
Brian gives us a snap shot of the Canadian R&D landscape, its promise, and how Canadian innovation has been impacted by COVID-19 and how it is contributing to the fight against COVID-19.
Brian is a true champion of our industry. To bring any new therapy to market requires a good idea, bright minds and a lot of money.
Brian and his team at Bloom Burton have helped a lot of smart people with bright ideas find the money to fund their dreams and bring new therapies to patients.This podcast was recorded on the heels of the 2020 Bloom Burton Award Gala hosted by Brian and his business partner, and fellow co-founder, Jolyon Burton. The award gala highlights what is possible when we fund smart people with bright ideas.
-
Several COVID19 vaccine candidates are in development and launch plans are being drafted.
Progress is unfolding at an unprecedented pace. More than 200 potential vaccines are in development and more than 40 have entered human trials. Applications for approval have already been submitted to Health Canada under the Interim Order.
Canada, currently, has access to a guaranteed 174 million doses of potential COVID19 vaccines. This represents over $1 billion in advance purchase agreements
Canada has also pledged to the World Health Organisation's Advanced Market Commitment (AMC) $220 million to purchase 15 million vaccine doses from the COVAX facility plus $220 million to purchase doses for low- and middle-income countries.
Securing regulatory approval and supply agreements is a great first step, but how will the vaccine be rolled out safely and equitable as possible?
To help us understand how industry in Canada is preparing for the roll out, Iāve invited Daniel Chiasson, President and CEO, of the Canadian Association for Pharmacy Distribution Management (CAPDM).
-
In this episode of The Pharma Podcast we discuss Considerations for an Evolved Pharma Commercial Model in the wake of COVID-19.
My guest is Tiana DiMichele, Director, Business Development, Impres Inc.
Contact Information:
Tiana DiMichele, Director, Business Development
Phone: (416) 885-0023 |
E-mail: [email protected] - Laat meer zien
